Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2002

Intracerebroventricular administration of bacterial lipopolysaccharide prevents the development of acute experimental pancreatitis in the rat.

Anna Leja, Ryszard Sendur, Katarzyna Nawrot, Joanna Bonior, Jolanta Jaworek, Jerzy Stachura, Wiesław Pawlik, Stanisław Konturek

Med Sci Monit 2002; 8(4): BR136-143 :: ID: 420879

Abstract

BACKGROUND: Lipopolysaccharides (LPS) are responsible for septic shockbut low doses of LPS reduce pancreatic damage produced by caerulein-induced pancreatitis (CIP) in rats.Leptin, produced by adipocytes attenuates the severity of CIP. The aim of this study was to evaluatethe effect of intracerebroventricular (i.c.v.) administration of LPS on CIP and plasma leptin level andto investigate the involvement of sensory nerves (SN) in the effects of LPS on CIP. MATERIAL/METHODS:CIP was produced by subcutaneous (s.c.) infusion of caerulein (25 Kg/kg) to conscious rats. SN were deactivatedwith capsaicin (100 mg/kg s.c.). LPS (0.2, 2, or 20 Kg/rat) were applied to the right cerebral ventricle30 min prior to CIP. RESULTS: CIP was manifested by an increase in plasma levels of amylase, lipase,leptin and an anti-inflammatory interleukin 10 (IL-10), (by 400%, 1000%, 700% and 50%, respectively),confirmed by histological examination and accompanied by 40% reduction in pancreatic blood flow. Pretreatmentof CIP rats with i.c.v. LPS resulted in significant reduction of CIP accompanied by dose-dependent increasein plasma levels of leptin and IL-10. Deactivation of SN, which by itself failed to affect CIP, completelyreversed the beneficial effects of i.c.v. administration of LPS on CIP and reduced plasma leptin andIL-10 concentrations. CONCLUSIONS: Pretreatment with LPS given i.c.v. prevents the development of caerulein-inducedpancreatitis through the activation of SN and though the release of leptin.

Keywords: Adipocytes, Afferent Pathways, amylases, Caerulein, Capsaicin, Comparative Study, Escherichia coli, Injections, Intraventricular, Interleukin-10, Leptin, Lipase, Neurons, Afferent, Rats, Wistar, Sympathectomy, Chemical

Add Comment 0 Comments

Editorial

01 April 2024 : Editorial  

Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug Resistance

Dinah V. Parums

DOI: 10.12659/MSM.944600

Med Sci Monit 2024; 30:e944600

0:00

In Press

06 Mar 2024 : Clinical Research  

Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943797  

21 Mar 2024 : Meta-Analysis  

Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...

Med Sci Monit In Press; DOI: 10.12659/MSM.943863  

10 Apr 2024 : Clinical Research  

Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...

Med Sci Monit In Press; DOI: 10.12659/MSM.942612  

06 Mar 2024 : Clinical Research  

Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...

Med Sci Monit In Press; DOI: 10.12659/MSM.941102  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750